Mechanisms linking gender-based violence to worse HIV treatment and care outcomes among women in the United States
- 10 August 2022
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 36 (13) , 1861-1869
Abstract
Objective: To test whether substance use mediates the associations between gender-based violence (GBV) and suboptimal adherence to antiretroviral therapy (ART), and GBV and poor engagement in care, among women living with HIV (WLHIV) in the United States (US). Design: We analyzed longitudinal data collected among 1717 WLHIV in the Women's Interagency HIV Study (WIHS). Methods: From 2013 to 2017, WLHIV completed semi-annual assessments on GBV, substance use, and HIV treatment and care. Adjusted multilevel logistic regression models were built to estimate the impact of GBV on; suboptimal (<95%) adherence and at least one missed HIV care appointment without rescheduling in the past 6 months. Mediation analyses were performed to test whether heavy drinking and illicit drug use mediated the associations between GBV and the two HIV outcomes. Results: The mean age was 47 (standard deviation = 9), 5% reported experiencing GBV, 17% reported suboptimal adherence and 15% reported at least one missed appointment in the past 6 months. Women who experienced GBV had a significantly higher odds of suboptimal adherence [adjusted odds ratio (aOR) = 1.99; 95% confidence interval (CI) = 1.40–2.83] and missed appointments (aOR = 1.92, 95% CI = 1.32–2.33). Heavy drinking and illicit drug use mediated 36 and 73% of the association between GBV and suboptimal adherence and 29 and 65% of the association between GBV and missed appointments, respectively. Conclusions: Substance use is an underlying mechanism through which GBV affects outcomes along the HIV care continuum among WLHIV in the US. To optimize HIV treatment and care among women, interventions should address the combined epidemics of substance use, violence, and HIV.Keywords
This publication has 44 references indexed in Scilit:
- Abuse and Resilience in Relation to HAART Medication Adherence and HIV Viral Load Among Women with HIV in the United StatesAIDS Patient Care and STDs, 2014
- A systematic review of interventions to reduce HIV‐related stigma and discrimination from 2002 to 2013: how far have we come?Journal of the International AIDS Society, 2013
- Critical Consciousness, Racial and Gender Discrimination, and HIV Disease Markers in African American Women with HIVAIDS and Behavior, 2013
- The Table 2 Fallacy: Presenting and Interpreting Confounder and Modifier CoefficientsAmerican Journal of Epidemiology, 2013
- Dual HIV risk and vulnerabilities among women who use or inject drugsCurrent Opinion in HIV and AIDS, 2012
- Intimate Partner Violence: A Predictor of Worse HIV Outcomes and Engagement in CareAIDS Patient Care and STDs, 2012
- Psychological Trauma and PTSD in HIV-Positive Women: A Meta-AnalysisAIDS and Behavior, 2012
- Substance use and HIV disease progression in the HAART era: Implications for the primary prevention of HIVLife Sciences, 2011
- Intimate Partner Violence and HIV Among Drug-Involved Women: Contexts Linking These Two Epidemics—Challenges and Implications for Prevention and TreatmentSubstance Use & Misuse, 2011
- HIV and women who use drugs: double neglect, double riskThe Lancet, 2010